MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON

MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON was reported 6173 times

MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STOMA SITE DERMATITIS 11 0.3333
1 HYPOCHOLESTEROLAEMIA 84 0.2380
2 OBSTRUCTIVE DEFAECATION 11 0.1642
3 HEPATIC ENZYME 19 0.1275
4 FACET JOINT SYNDROME 336 0.1031
5 GASTROINTESTINAL STOMA OUTPUT ABNORMAL 11 0.0759
6 RHEUMATIC FEVER 335 0.0751
7 PERIPHERAL VENOUS DISEASE 299 0.0731
8 ONYCHOMADESIS 296 0.0705
9 DISLOCATION OF VERTEBRA 137 0.0600
10 ONYCHOMYCOSIS 256 0.0583
11 BLEPHAROSPASM 361 0.0573
12 LUPUS VULGARIS 65 0.0516
13 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 106 0.0511
14 BURKHOLDERIA TEST POSITIVE 6 0.0484
15 BREAST CANCER STAGE III 311 0.0480
16 RETINITIS 80 0.0463
17 DEEP VEIN THROMBOSIS POSTOPERATIVE 90 0.0449
18 SWOLLEN JOINT COUNT INCREASED 143 0.0448
19 VISUAL SNOW SYNDROME 8 0.0430
20 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 308 0.0429
21 DUODENAL ULCER PERFORATION 310 0.0416
22 C-REACTIVE PROTEIN ABNORMAL 267 0.0416
23 ANTICIPATORY ANXIETY 11 0.0404
24 SERONEGATIVE ARTHRITIS 42 0.0366
25 X-RAY ABNORMAL 64 0.0358
26 CONVULSIONS LOCAL 7 0.0354
27 FINGER DEFORMITY 160 0.0330
28 FOLLICULITIS 346 0.0330
29 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 18 0.0321
30 MUSCLE INJURY 265 0.0320
31 LIP DRY 288 0.0317
32 PEMPHIGUS 395 0.0316
33 GRIP STRENGTH DECREASED 264 0.0300
34 HYPERCHOLESTEROLAEMIA 281 0.0291
35 NAIL DISORDER 252 0.0288
36 HELICOBACTER INFECTION 291 0.0283
37 SWOLLEN JOINT COUNT 7 0.0280
38 BURSITIS 335 0.0276
39 INFUSION SITE REACTION 80 0.0268
40 LIVE BIRTH 218 0.0260
41 JOINT RANGE OF MOTION DECREASED 329 0.0245
42 PERICARDITIS 410 0.0244
43 C-REACTIVE PROTEIN 22 0.0237
44 RHEUMATOID FACTOR POSITIVE 137 0.0237
45 CONGENITAL ANOMALY 180 0.0232
46 PORPHYRIA ACUTE 33 0.0230
47 OVERLAP SYNDROME 16 0.0229
48 PRODUCT LABEL CONFUSION 133 0.0228
49 BACK INJURY 240 0.0220
50 SYNOVITIS 397 0.0220
51 WOUND INFECTION 241 0.0220
52 GRIP STRENGTH 5 0.0218
53 HAND DEFORMITY 282 0.0215
54 BONE EROSION 76 0.0215
55 TASTE DISORDER 350 0.0172
56 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 11 0.0165
57 IRRITABLE BOWEL SYNDROME 349 0.0163
58 STOMA SITE INFLAMMATION 12 0.0161
59 GLOSSODYNIA 349 0.0156
60 OBESITY 247 0.0155
61 WOUND 412 0.0147
62 FIBROMYALGIA 356 0.0146
63 COELIAC DISEASE 143 0.0146
64 NERVE BLOCK 8 0.0137
65 SPONDYLITIS 48 0.0132
66 CONTRAINDICATED PRODUCT ADMINISTERED 399 0.0132
67 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 21 0.0131
68 DRUG TOLERANCE 63 0.0124
69 LIVER INJURY 304 0.0124
70 HYPERMAGNESAEMIA 8 0.0123
71 DRUG TOLERANCE DECREASED 33 0.0117
72 EXOSTOSIS 103 0.0113
73 NORMAL NEWBORN 61 0.0112
74 TYPE 2 DIABETES MELLITUS 374 0.0111
75 EPILEPSY 336 0.0110
76 RED BLOOD CELL SEDIMENTATION RATE INCREASED 120 0.0108
77 GASTRIC VARICES 5 0.0106
78 IMPAIRED HEALING 347 0.0106
79 NIGHT SWEATS 338 0.0105
80 FAECAL VOLUME DECREASED 5 0.0104
81 PSORIATIC ARTHROPATHY 420 0.0103
82 C-REACTIVE PROTEIN INCREASED 375 0.0103
83 ADVERSE REACTION 135 0.0102
84 SYSTEMIC LUPUS ERYTHEMATOSUS 360 0.0101
85 RHONCHI 14 0.0101
86 LIVER FUNCTION TEST INCREASED 217 0.0101
87 ULCER HAEMORRHAGE 68 0.0100
88 BREAST CANCER STAGE II 76 0.0091
89 AUTOIMMUNE DISORDER 87 0.0089
90 PRURITUS ALLERGIC 10 0.0086
91 BLOOD CHOLESTEROL INCREASED 396 0.0085
92 SEIZURE CLUSTER 7 0.0084
93 THERAPEUTIC PRODUCT EFFECT DECREASED 377 0.0084
94 GASTROINTESTINAL BACTERIAL OVERGROWTH 5 0.0083
95 STOMA SITE PAIN 12 0.0082
96 GAIT INABILITY 269 0.0080
97 PRESCRIBED OVERDOSE 149 0.0077
98 TETANY 14 0.0077
99 PRODUCT CONTAMINATION MICROBIAL 9 0.0075
100 OSTEOARTHRITIS 308 0.0073
101 GASTROINTESTINAL STOMA COMPLICATION 11 0.0070
102 CERUMEN IMPACTION 6 0.0066
103 INFUSION RELATED REACTION 429 0.0065
104 BLOOD UREA DECREASED 8 0.0064
105 LUNG DISORDER 309 0.0063
106 LOWER RESPIRATORY TRACT INFECTION 286 0.0063
107 LUPUS-LIKE SYNDROME 57 0.0063
108 INFLAMMATION 323 0.0063
109 EXCESSIVE GRANULATION TISSUE 5 0.0062
110 GASTROOESOPHAGEAL REFLUX DISEASE 497 0.0062
111 BLISTER 339 0.0060
112 SLEEP DISORDER 417 0.0059
113 HEPATITIS 151 0.0059
114 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 100 0.0058
115 HEPATIC ENZYME INCREASED 397 0.0058
116 SCIATICA 92 0.0058
117 DERMATITIS EXFOLIATIVE GENERALISED 20 0.0057
118 WALKING AID USER 37 0.0056
119 UNDERWEIGHT 11 0.0056
120 BLOOD MAGNESIUM INCREASED 5 0.0055
121 PRESCRIBED UNDERDOSE 110 0.0055
122 DRUG-INDUCED LIVER INJURY 170 0.0054
123 CORTISOL DECREASED 6 0.0052
124 ILL-DEFINED DISORDER 319 0.0052
125 ARTHROPATHY 291 0.0052
126 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 12 0.0052
127 RECALLED PRODUCT 9 0.0052
128 WHEEZING 308 0.0052
129 FAECES HARD 20 0.0051
130 DRY MOUTH 412 0.0051
131 MOBILITY DECREASED 360 0.0050
132 RECALLED PRODUCT ADMINISTERED 47 0.0049
133 BODY TEMPERATURE ABNORMAL 9 0.0049
134 LUMBAR VERTEBRAL FRACTURE 22 0.0048
135 PULMONARY FIBROSIS 92 0.0048
136 MIGRAINE 455 0.0048
137 INJURY 333 0.0047
138 TREATMENT FAILURE 392 0.0047
139 MALLORY-WEISS SYNDROME 6 0.0047
140 STOMATITIS 285 0.0047
141 PUSTULAR PSORIASIS 16 0.0047
142 EYE INJURY 14 0.0046
143 EAR PAIN 89 0.0046
144 MATERNAL EXPOSURE TIMING UNSPECIFIED 17 0.0045
145 JOINT DESTRUCTION 7 0.0045
146 PLASMA CELL MYELOMA REFRACTORY 6 0.0045
147 MUSCULOSKELETAL PAIN 232 0.0044
148 HEPATIC CIRRHOSIS 82 0.0044
149 INTENTIONAL PRODUCT USE ISSUE 379 0.0043
150 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 28 0.0043
151 MATERNAL EXPOSURE DURING PREGNANCY 379 0.0042
152 EXPOSURE DURING PREGNANCY 264 0.0042
153 LABELLED DRUG-DRUG INTERACTION ISSUE 6 0.0041
154 SWELLING 387 0.0041
155 BLOOD IMMUNOGLOBULIN G INCREASED 5 0.0041
156 LUMBAR SPINAL STENOSIS 12 0.0041
157 COMPLEX REGIONAL PAIN SYNDROME 6 0.0041
158 NECK PAIN 224 0.0040
159 LOWER LIMB FRACTURE 77 0.0040
160 HYPERAESTHESIA TEETH 5 0.0040
161 NEURITIS 6 0.0039
162 EYE ALLERGY 6 0.0039
163 COSTOCHONDRITIS 6 0.0037
164 INJECTION SITE REACTION 249 0.0036
165 RHEUMATOID ARTHRITIS 409 0.0036
166 EARLY SATIETY 7 0.0036
167 DELIRIUM 124 0.0036
168 JOINT SWELLING 425 0.0035
169 DRUG INTOLERANCE 340 0.0035
170 RASH VESICULAR 17 0.0035
171 SPINAL FUSION SURGERY 14 0.0034
172 DYSPEPSIA 334 0.0034
173 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 240 0.0034
174 GENERAL PHYSICAL HEALTH DETERIORATION 390 0.0034
175 OPHTHALMIC HERPES ZOSTER 6 0.0033
176 NEPHROGENIC ANAEMIA 15 0.0032
177 MUSCULOSKELETAL STIFFNESS 281 0.0032
178 FREQUENT BOWEL MOVEMENTS 86 0.0032
179 JOINT STIFFNESS 83 0.0032
180 MEMORY IMPAIRMENT 427 0.0031
181 NASAL SEPTUM DEVIATION 6 0.0031
182 OEDEMA 166 0.0031
183 GASTROINTESTINAL DISORDER 272 0.0030
184 BLOOD MAGNESIUM DECREASED 26 0.0030
185 MENOPAUSAL SYMPTOMS 7 0.0030
186 COMPRESSION FRACTURE 16 0.0030
187 VARICES OESOPHAGEAL 9 0.0030
188 EYELID PAIN 6 0.0029
189 FOOD AVERSION 5 0.0029
190 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 141 0.0029
191 LONG QT SYNDROME 7 0.0029
192 CONFUSIONAL STATE 471 0.0029
193 ABDOMINAL DISTENSION 302 0.0029
194 PRE-EXISTING CONDITION IMPROVED 18 0.0029
195 PERIPHERAL SWELLING 444 0.0029
196 JOINT DISLOCATION 30 0.0028
197 DISCOMFORT 171 0.0028
198 HYPERAESTHESIA 23 0.0028
199 MENOPAUSE 7 0.0027
200 THERAPY NON-RESPONDER 122 0.0027
201 ABDOMINAL DISCOMFORT 454 0.0027
202 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 7 0.0026
203 FOOT DEFORMITY 29 0.0026
204 MUSCLE SPASMS 477 0.0026
205 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 44 0.0026
206 ATROPHY 5 0.0026
207 MUSCULAR WEAKNESS 291 0.0026
208 TENOSYNOVITIS 7 0.0025
209 HYPOAESTHESIA 379 0.0025
210 PRODUCT QUALITY ISSUE 339 0.0025
211 BRAIN FOG 39 0.0025
212 PARAESTHESIA 388 0.0025
213 ABDOMINAL PAIN UPPER 507 0.0025
214 PRODUCT ADMINISTRATION INTERRUPTED 19 0.0024
215 DEVICE INFUSION ISSUE 6 0.0024
216 DRUG USE DISORDER 20 0.0024
217 BOWEL MOVEMENT IRREGULARITY 18 0.0023
218 TENDERNESS 24 0.0023
219 URINE OUTPUT INCREASED 6 0.0023
220 OSTEOPOROSIS 94 0.0023
221 DEFAECATION URGENCY 16 0.0023
222 GENERAL SYMPTOM 17 0.0023
223 FAECES PALE 5 0.0022
224 WHITE BLOOD CELL DISORDER 6 0.0022
225 MYOSITIS 20 0.0022
226 INFUSION SITE PRURITUS 7 0.0022
227 GASTROINTESTINAL HYPOMOTILITY 5 0.0022
228 TRIGGER FINGER 9 0.0022
229 TIC 12 0.0022
230 HICCUPS 18 0.0022
231 FAECALOMA 12 0.0022
232 RESPIRATORY DISORDER 65 0.0022
233 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
234 HIP ARTHROPLASTY 33 0.0022
235 DEPRESSION 485 0.0021
236 GASTROINTESTINAL PAIN 23 0.0021
237 DISABILITY 41 0.0021
238 CONTUSION 199 0.0021
239 CARBOHYDRATE ANTIGEN 125 INCREASED 7 0.0021
240 HYPERTENSION 430 0.0020
241 ASPIRATION 22 0.0020
242 WEIGHT FLUCTUATION 21 0.0020
243 AMNESIA 130 0.0020
244 HYPERPARATHYROIDISM SECONDARY 5 0.0020
245 SUSPECTED OFF LABEL USE 9 0.0020
246 URTICARIA 331 0.0020
247 DYSCHEZIA 6 0.0020
248 ABNORMAL FAECES 16 0.0020
249 CONSTIPATION 424 0.0019
250 WEIGHT INCREASED 434 0.0019
251 ALOPECIA 376 0.0019
252 UNDERDOSE 139 0.0019
253 MATERNAL EXPOSURE BEFORE PREGNANCY 13 0.0019
254 LARGE INTESTINE POLYP 13 0.0019
255 TUMOUR MARKER INCREASED 9 0.0019
256 HEPATIC PAIN 8 0.0019
257 GASTROINTESTINAL MOTILITY DISORDER 10 0.0019
258 PROTEIN TOTAL DECREASED 7 0.0019
259 KNEE ARTHROPLASTY 39 0.0019
260 PARANASAL SINUS DISCOMFORT 7 0.0018
261 NASOPHARYNGITIS 338 0.0018
262 INSURANCE ISSUE 28 0.0018
263 DIVERTICULUM INTESTINAL 8 0.0018
264 HYPERVOLAEMIA 9 0.0018
265 SPINAL COMPRESSION FRACTURE 15 0.0018
266 LYME DISEASE 6 0.0018
267 HYPERSENSITIVITY 332 0.0018
268 PROSTATOMEGALY 7 0.0018
269 BLOOD CALCIUM DECREASED 20 0.0018
270 PRODUCT USE IN UNAPPROVED INDICATION 440 0.0018
271 FOETAL EXPOSURE DURING PREGNANCY 141 0.0017
272 RENAL FUNCTION TEST ABNORMAL 8 0.0017
273 SERUM FERRITIN INCREASED 9 0.0017
274 ADVERSE DRUG REACTION 152 0.0017
275 PRODUCT CONTAMINATION 6 0.0017
276 PRODUCT USE ISSUE 312 0.0017
277 ADVERSE EVENT 150 0.0016
278 INSOMNIA 432 0.0016
279 DECREASED APPETITE 376 0.0016
280 TENDON INJURY 6 0.0016
281 HYPERACUSIS 6 0.0016
282 CHRONIC SINUSITIS 6 0.0016
283 ASTHENIA 600 0.0016
284 IMMUNOSUPPRESSION 14 0.0016
285 LIVER DISORDER 70 0.0016
286 UPPER-AIRWAY COUGH SYNDROME 13 0.0016
287 FEELING HOT 96 0.0016
288 MEDICATION ERROR 87 0.0016
289 GAIT DISTURBANCE 297 0.0016
290 VASCULAR DEVICE INFECTION 7 0.0015
291 EAR INFECTION 41 0.0015
292 TENDON DISORDER 10 0.0015
293 ELECTROCARDIOGRAM ABNORMAL 12 0.0015
294 NAIL DISCOLOURATION 6 0.0015
295 PLEURISY 9 0.0015
296 ANORECTAL DISCOMFORT 8 0.0015
297 MITRAL VALVE INCOMPETENCE 17 0.0015
298 FOREIGN BODY 6 0.0015
299 ANXIETY DISORDER 5 0.0015
300 SKIN PAPILLOMA 6 0.0015
301 FRUSTRATION TOLERANCE DECREASED 12 0.0015
302 SEASONAL ALLERGY 21 0.0015
303 STRESS FRACTURE 8 0.0015
304 SPINAL COLUMN STENOSIS 7 0.0015
305 ROAD TRAFFIC ACCIDENT 62 0.0015
306 FACIAL PAIN 13 0.0015
307 FEEDING DISORDER 29 0.0014
308 BREATH SOUNDS ABNORMAL 7 0.0014
309 APHTHOUS ULCER 11 0.0014
310 INTERVERTEBRAL DISC PROTRUSION 31 0.0014
311 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
312 SINUSITIS 144 0.0014
313 FLUID INTAKE REDUCED 7 0.0014
314 NEURALGIA 34 0.0014
315 IMPAIRED GASTRIC EMPTYING 19 0.0014
316 ATRIOVENTRICULAR BLOCK FIRST DEGREE 6 0.0014
317 ARTHRALGIA 572 0.0014
318 SLEEP APNOEA SYNDROME 26 0.0014
319 DECREASED INTEREST 8 0.0014
320 SENSITIVE SKIN 10 0.0014
321 BACK DISORDER 22 0.0014
322 ILEUS PARALYTIC 6 0.0013
323 CARDIAC DYSFUNCTION 5 0.0013
324 CONDITION AGGRAVATED 408 0.0013
325 MUSCLE ATROPHY 17 0.0013
326 FLATULENCE 76 0.0013
327 PAIN IN EXTREMITY 393 0.0013
328 POLYARTHRITIS 7 0.0013
329 RASH 578 0.0013
330 ADRENAL INSUFFICIENCY 16 0.0013
331 UMBILICAL HERNIA 6 0.0013
332 EPIGASTRIC DISCOMFORT 5 0.0013
333 NONSPECIFIC REACTION 7 0.0013
334 ARTERIOSCLEROSIS 12 0.0013
335 PULMONARY TOXICITY 9 0.0013
336 PROSTATIC DISORDER 7 0.0013
337 PAIN 776 0.0013
338 BLOOD ALBUMIN DECREASED 10 0.0013
339 TEMPERATURE INTOLERANCE 13 0.0013
340 RENAL CYST 10 0.0013
341 BLEPHARITIS 5 0.0012
342 INFECTION 180 0.0012
343 RHINITIS 10 0.0012
344 NEUROLOGICAL SYMPTOM 7 0.0012
345 HYPOPHOSPHATAEMIA 9 0.0012
346 HOSPICE CARE 12 0.0012
347 DIZZINESS 605 0.0012
348 RESTLESS LEGS SYNDROME 22 0.0012
349 PULMONARY MASS 18 0.0012
350 ABDOMINAL TENDERNESS 6 0.0012
351 SKIN WARM 7 0.0012
352 WHITE BLOOD CELL COUNT INCREASED 46 0.0012
353 CHOLECYSTITIS CHRONIC 8 0.0012
354 PNEUMONIA 386 0.0012
355 TENDON PAIN 9 0.0012
356 INFUSION SITE ERYTHEMA 10 0.0012
357 DIARRHOEA 760 0.0012
358 JOINT INJURY 25 0.0012
359 DEVICE RELATED INFECTION 18 0.0012
360 ABDOMINAL PAIN 270 0.0012
361 VOMITING 542 0.0012
362 INGUINAL HERNIA 7 0.0011
363 MALABSORPTION 6 0.0011
364 RECTAL HAEMORRHAGE 49 0.0011
365 GROIN PAIN 10 0.0011
366 ATELECTASIS 11 0.0011
367 SPINAL OSTEOARTHRITIS 10 0.0011
368 PULMONARY CONGESTION 15 0.0011
369 TUMOUR LYSIS SYNDROME 10 0.0011
370 HYPERCALCAEMIA 14 0.0011
371 PIGMENTATION DISORDER 7 0.0011
372 GENERALISED OEDEMA 14 0.0011
373 SCOLIOSIS 7 0.0011
374 FALL 375 0.0011
375 NASAL DRYNESS 7 0.0011
376 HYPERSOMNIA 32 0.0011
377 BLOOD SODIUM DECREASED 21 0.0011
378 BRUXISM 6 0.0011
379 INFUSION SITE SWELLING 7 0.0011
380 MUSCLE TIGHTNESS 18 0.0011
381 BLOOD POTASSIUM INCREASED 18 0.0011
382 GASTROENTERITIS VIRAL 20 0.0011
383 ASTHMA 125 0.0011
384 HEADACHE 693 0.0011
385 DECUBITUS ULCER 9 0.0011
386 BLOOD POTASSIUM DECREASED 33 0.0011
387 LABORATORY TEST ABNORMAL 32 0.0011
388 GASTRIC ULCER HAEMORRHAGE 6 0.0011
389 DRY THROAT 11 0.0011
390 CEREBRAL DISORDER 8 0.0011
391 PNEUMONIA ASPIRATION 27 0.0011
392 TOOTH ABSCESS 11 0.0011
393 PANCREATITIS 57 0.0011
394 BODY TEMPERATURE INCREASED 22 0.0011
395 HAEMORRHOIDS 21 0.0011
396 FATIGUE 836 0.0011
397 HEAD DISCOMFORT 19 0.0011
398 OCULAR DISCOMFORT 12 0.0011
399 SENSATION OF FOREIGN BODY 9 0.0011
400 FLUID RETENTION 54 0.0011
401 WEIGHT DECREASED 295 0.0011
402 HYPOCALCAEMIA 20 0.0011
403 NAUSEA 836 0.0011
404 GASTRIC ULCER 20 0.0011
405 PARALYSIS 15 0.0010
406 RENAL FAILURE CHRONIC 8 0.0010
407 UPPER RESPIRATORY TRACT INFECTION 48 0.0010
408 ERUCTATION 20 0.0010
409 MALAISE 450 0.0010
410 HEREDITARY ANGIOEDEMA 11 0.0010
411 HAEMORRHOIDAL HAEMORRHAGE 5 0.0010
412 MULTIPLE ALLERGIES 8 0.0010
413 DYSPNOEA 577 0.0010
414 MIDDLE INSOMNIA 19 0.0010
415 VITREOUS FLOATERS 10 0.0010
416 SKIN LACERATION 11 0.0010
417 SINUS DISORDER 20 0.0010
418 TRICUSPID VALVE INCOMPETENCE 8 0.0010
419 IMMUNODEFICIENCY 15 0.0010
420 CYSTITIS 32 0.0010
421 OEDEMA PERIPHERAL 122 0.0010
422 ANAL INCONTINENCE 9 0.0010
423 CARPAL TUNNEL SYNDROME 14 0.0010
424 TOOTH FRACTURE 11 0.0010
425 BLOOD PRESSURE INADEQUATELY CONTROLLED 6 0.0010
426 NODULE 13 0.0010
427 NOCTURIA 12 0.0010
428 DYSPNOEA EXERTIONAL 37 0.0010
429 INCREASED TENDENCY TO BRUISE 9 0.0010
430 SMALL INTESTINAL OBSTRUCTION 12 0.0010
431 TENDON RUPTURE 12 0.0010
432 HYPOTHYROIDISM 31 0.0010
433 LIMB DISCOMFORT 30 0.0010
434 INCORRECT PRODUCT ADMINISTRATION DURATION 21 0.0010
435 NEUROPATHY PERIPHERAL 92 0.0010
436 CHEST PAIN 179 0.0010
437 HEPATIC STEATOSIS 18 0.0010
438 FAILURE TO THRIVE 5 0.0010
439 VENTRICULAR EXTRASYSTOLES 10 0.0010
440 SINUS CONGESTION 13 0.0010
441 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
442 APATHY 14 0.0010
443 URINARY RETENTION 32 0.0010
444 SWELLING OF EYELID 6 0.0010
445 DERMATITIS ALLERGIC 12 0.0010
446 VISUAL IMPAIRMENT 117 0.0009
447 WHITE BLOOD CELL COUNT ABNORMAL 6 0.0009
448 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
449 PROCTALGIA 6 0.0009
450 COORDINATION ABNORMAL 13 0.0009
451 ANXIETY 265 0.0009
452 ECONOMIC PROBLEM 14 0.0009
453 ERYTHEMA OF EYELID 5 0.0009
454 VITAMIN D DEFICIENCY 9 0.0009
455 BLOOD PRESSURE FLUCTUATION 22 0.0009
456 HOT FLUSH 69 0.0009
457 THERAPY CHANGE 9 0.0009
458 BODY TEMPERATURE DECREASED 9 0.0009
459 PROCEDURAL COMPLICATION 7 0.0009
460 CONCUSSION 7 0.0009
461 CYSTIC FIBROSIS 5 0.0009
462 DIVERTICULITIS 25 0.0009
463 NO THERAPEUTIC RESPONSE 11 0.0009
464 CARDIAC FAILURE ACUTE 6 0.0009
465 SPINAL FRACTURE 18 0.0009
466 OFF LABEL USE 777 0.0009
467 HEART RATE IRREGULAR 20 0.0009
468 CHOLECYSTITIS ACUTE 5 0.0009
469 GINGIVAL PAIN 7 0.0009
470 GINGIVAL BLEEDING 12 0.0009
471 SCAB 10 0.0009
472 MICTURITION URGENCY 10 0.0009
473 GASTRITIS 23 0.0009
474 LYMPHOEDEMA 6 0.0009
475 MUSCLE DISORDER 7 0.0009
476 LARGE INTESTINE PERFORATION 6 0.0009
477 HYPERTRANSAMINASAEMIA 6 0.0009
478 POST PROCEDURAL INFECTION 7 0.0009
479 POLYURIA 7 0.0009
480 HYPOVOLAEMIA 5 0.0009
481 COLD SWEAT 15 0.0009
482 HIATUS HERNIA 11 0.0008
483 RENAL PAIN 9 0.0008
484 VENTRICULAR TACHYCARDIA 14 0.0008
485 ENERGY INCREASED 5 0.0008
486 PLATELET COUNT INCREASED 11 0.0008
487 BODY HEIGHT DECREASED 9 0.0008
488 MUSCULOSKELETAL CHEST PAIN 13 0.0008
489 TENDONITIS 13 0.0008
490 LUNG INFECTION 13 0.0008
491 NASAL CONGESTION 49 0.0008
492 LEUKOCYTOSIS 15 0.0008
493 URINARY TRACT INFECTION 141 0.0008
494 CORONARY ARTERY DISEASE 25 0.0008
495 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
496 BRONCHITIS 61 0.0008
497 EYE DISORDER 27 0.0008
498 PSEUDOMONAS INFECTION 7 0.0008
499 MUSCLE SPASTICITY 10 0.0008
500 PALPITATIONS 95 0.0008
501 PYELONEPHRITIS 7 0.0008
502 INTENTIONAL DOSE OMISSION 23 0.0008
503 CYST 10 0.0008
504 RED BLOOD CELL COUNT DECREASED 23 0.0008
505 ARRHYTHMIA 38 0.0008
506 THERAPEUTIC RESPONSE UNEXPECTED 36 0.0008
507 SKIN INFECTION 9 0.0008
508 INTESTINAL PERFORATION 9 0.0008
509 OVARIAN CYST 8 0.0008
510 EYE INFECTION 9 0.0008
511 OSTEOPENIA 12 0.0008
512 CHRONIC KIDNEY DISEASE 60 0.0008
513 HUNGER 11 0.0008
514 DYSSTASIA 23 0.0008
515 MOOD SWINGS 25 0.0008
516 THROAT IRRITATION 35 0.0008
517 PAIN IN JAW 22 0.0008
518 ATRIOVENTRICULAR BLOCK 6 0.0008
519 INFUSION SITE PAIN 10 0.0008
520 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
521 ELECTROLYTE IMBALANCE 9 0.0008
522 CANDIDA INFECTION 13 0.0008
523 HERPES SIMPLEX 5 0.0008
524 ANGER 26 0.0008
525 BONE PAIN 45 0.0008
526 RESPIRATORY TRACT INFECTION 20 0.0008
527 END STAGE RENAL DISEASE 14 0.0008
528 LETHARGY 44 0.0008
529 AFFECTIVE DISORDER 6 0.0008
530 COLITIS ULCERATIVE 34 0.0008
531 NERVE COMPRESSION 7 0.0008
532 PYREXIA 262 0.0008
533 FURUNCLE 6 0.0008
534 INCONTINENCE 8 0.0008
535 PRODUCT DISTRIBUTION ISSUE 7 0.0008
536 BLOOD PRESSURE ABNORMAL 15 0.0008
537 FEELING COLD 21 0.0008
538 ULCER 12 0.0008
539 HYPERLIPIDAEMIA 9 0.0008
540 BLOOD PRESSURE INCREASED 115 0.0008
541 ATRIAL FLUTTER 6 0.0008
542 DEHYDRATION 100 0.0007
543 ASCITES 22 0.0007
544 FLANK PAIN 7 0.0007
545 SENSORY LOSS 6 0.0007
546 FULL BLOOD COUNT DECREASED 15 0.0007
547 INTESTINAL OBSTRUCTION 28 0.0007
548 PRODUCT TASTE ABNORMAL 10 0.0007
549 FOOT FRACTURE 14 0.0007
550 LYMPHOCYTE COUNT DECREASED 13 0.0007
551 DYSURIA 27 0.0007
552 ABNORMAL LOSS OF WEIGHT 5 0.0007
553 OESOPHAGITIS 8 0.0007
554 ECCHYMOSIS 5 0.0007
555 ACUTE RESPIRATORY FAILURE 14 0.0007
556 PHOTOSENSITIVITY REACTION 12 0.0007
557 ILEUS 9 0.0007
558 HAIR GROWTH ABNORMAL 5 0.0007
559 DIZZINESS POSTURAL 7 0.0007
560 MALNUTRITION 8 0.0007
561 HYPOKALAEMIA 33 0.0007
562 BACK PAIN 166 0.0007
563 BONE DISORDER 13 0.0007
564 OROPHARYNGEAL PAIN 66 0.0007
565 FEBRILE NEUTROPENIA 47 0.0007
566 NERVOUSNESS 37 0.0007
567 VERTIGO 43 0.0007
568 DIVERTICULUM 5 0.0007
569 THROAT TIGHTNESS 19 0.0007
570 VITAMIN D DECREASED 6 0.0007
571 DRY EYE 35 0.0007
572 CHOLECYSTECTOMY 8 0.0007
573 PREGNANCY 14 0.0007
574 MUSCULOSKELETAL DISCOMFORT 12 0.0007
575 MUSCLE STRAIN 6 0.0007
576 CARDIAC MURMUR 6 0.0007
577 SYNCOPE 69 0.0007
578 ORTHOSTATIC HYPOTENSION 12 0.0007
579 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
580 MOTOR DYSFUNCTION 7 0.0007
581 TACHYCARDIA 61 0.0007
582 MOVEMENT DISORDER 22 0.0007
583 SPLENOMEGALY 8 0.0007
584 BALANCE DISORDER 59 0.0007
585 INITIAL INSOMNIA 7 0.0007
586 EAR DISCOMFORT 7 0.0007
587 SEPSIS 76 0.0007
588 RIB FRACTURE 14 0.0007
589 HYPONATRAEMIA 38 0.0007
590 TOOTH DISORDER 15 0.0007
591 BACTERAEMIA 8 0.0007
592 FEELING DRUNK 5 0.0007
593 HERNIA 13 0.0007
594 PULMONARY HYPERTENSION 14 0.0007
595 POLLAKIURIA 28 0.0007
596 HYDRONEPHROSIS 5 0.0007
597 VIRAL INFECTION 22 0.0007
598 ILLNESS 68 0.0007
599 TREATMENT NONCOMPLIANCE 36 0.0007
600 EATING DISORDER 14 0.0007
601 ATRIAL FIBRILLATION 64 0.0007
602 SKIN LESION 18 0.0007
603 HEART RATE INCREASED 65 0.0007
604 ACCIDENTAL OVERDOSE 24 0.0007
605 EYE PAIN 37 0.0007
606 EYE PRURITUS 22 0.0007
607 NEPHROLITHIASIS 30 0.0007
608 TINNITUS 30 0.0007
609 RETINAL DETACHMENT 6 0.0007
610 HOSPITALISATION 100 0.0007
611 MUSCLE TWITCHING 15 0.0007
612 CARDIOMEGALY 8 0.0006
613 PRODUCTIVE COUGH 31 0.0006
614 DECREASED ACTIVITY 7 0.0006
615 ANHEDONIA 17 0.0006
616 FEELING ABNORMAL 155 0.0006
617 HYPOMAGNESAEMIA 9 0.0006
618 ANKLE FRACTURE 10 0.0006
619 DELUSION 10 0.0006
620 HYPOALBUMINAEMIA 5 0.0006
621 WITHDRAWAL SYNDROME 27 0.0006
622 URINARY INCONTINENCE 19 0.0006
623 ASPARTATE AMINOTRANSFERASE INCREASED 34 0.0006
624 PHOTOPHOBIA 12 0.0006
625 LACERATION 6 0.0006
626 RHINORRHOEA 41 0.0006
627 SINUS TACHYCARDIA 9 0.0006
628 BLOOD PRESSURE DECREASED 42 0.0006
629 DISTURBANCE IN ATTENTION 34 0.0006
630 RESPIRATORY TRACT CONGESTION 10 0.0006
631 RASH PRURITIC 34 0.0006
632 HYPOPHAGIA 16 0.0006
633 ROTATOR CUFF SYNDROME 8 0.0006
634 COGNITIVE DISORDER 29 0.0006
635 SINUS BRADYCARDIA 6 0.0006
636 SKIN ULCER 16 0.0006
637 DYSPHONIA 36 0.0006
638 GASTRIC DISORDER 21 0.0006
639 DECREASED IMMUNE RESPONSIVENESS 6 0.0006
640 HERPES ZOSTER 35 0.0006
641 WHITE BLOOD CELL COUNT DECREASED 66 0.0006
642 LIGAMENT SPRAIN 6 0.0006
643 STAPHYLOCOCCAL INFECTION 20 0.0006
644 INABILITY TO AFFORD MEDICATION 6 0.0006
645 EMBOLISM 5 0.0006
646 FAECES DISCOLOURED 13 0.0006
647 BURNING SENSATION 42 0.0006
648 ARTHRITIS 47 0.0006
649 VISION BLURRED 82 0.0006
650 HYPOAESTHESIA ORAL 9 0.0006
651 FEAR 16 0.0006
652 DRUG INEFFECTIVE 782 0.0006
653 MELAENA 13 0.0006
654 EUPHORIC MOOD 6 0.0006
655 SCAR 10 0.0006
656 THYROID DISORDER 9 0.0006
657 EMOTIONAL DISORDER 18 0.0006
658 INTENTIONAL PRODUCT MISUSE 51 0.0006
659 PRURITUS 223 0.0006
660 PARANOIA 10 0.0006
661 RASH PAPULAR 13 0.0006
662 DYSPHAGIA 55 0.0006
663 SUICIDAL IDEATION 53 0.0006
664 PROTEINURIA 11 0.0006
665 EYE DISCHARGE 6 0.0006
666 PANIC ATTACK 21 0.0006
667 PANCYTOPENIA 32 0.0006
668 PRODUCT USE COMPLAINT 9 0.0006
669 SOMNOLENCE 115 0.0006
670 BLOOD CALCIUM INCREASED 5 0.0006
671 FULL BLOOD COUNT ABNORMAL 6 0.0006
672 LYMPHADENOPATHY 20 0.0006
673 ORAL HERPES 11 0.0006
674 BREAST PAIN 6 0.0006
675 IMPAIRED WORK ABILITY 12 0.0006
676 KIDNEY INFECTION 11 0.0006
677 AGGRESSION 28 0.0006
678 HYPERHIDROSIS 72 0.0006
679 RENAL DISORDER 26 0.0006
680 HAEMARTHROSIS 5 0.0006
681 GOUT 10 0.0006
682 PAIN OF SKIN 15 0.0006
683 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
684 PRODUCT SUBSTITUTION ISSUE 32 0.0006
685 BLOOD BILIRUBIN INCREASED 15 0.0006
686 HAEMATOCRIT DECREASED 11 0.0006
687 HAEMATEMESIS 14 0.0006
688 HYPOKINESIA 8 0.0006
689 PELVIC PAIN 10 0.0005
690 GASTROENTERITIS 8 0.0005
691 SURGERY 32 0.0005
692 HALLUCINATION 41 0.0005
693 RASH ERYTHEMATOUS 26 0.0005
694 DENTAL CARIES 6 0.0005
695 UNEVALUABLE EVENT 41 0.0005
696 MYALGIA 92 0.0005
697 HEART RATE DECREASED 19 0.0005
698 PROCEDURAL PAIN 15 0.0005
699 VENTRICULAR FIBRILLATION 6 0.0005
700 NEUTROPHIL COUNT DECREASED 22 0.0005
701 NERVE INJURY 6 0.0005
702 CONJUNCTIVITIS 10 0.0005
703 HAEMOPTYSIS 15 0.0005
704 PRODUCT DOSE OMISSION ISSUE 158 0.0005
705 CELLULITIS 27 0.0005
706 PLATELET COUNT DECREASED 57 0.0005
707 PRESYNCOPE 13 0.0005
708 OXYGEN SATURATION DECREASED 30 0.0005
709 BEDRIDDEN 7 0.0005
710 ORAL CANDIDIASIS 7 0.0005
711 DYSARTHRIA 20 0.0005
712 SARS-COV-2 TEST POSITIVE 7 0.0005
713 DEPRESSED MOOD 28 0.0005
714 LACRIMATION INCREASED 16 0.0005
715 IMPAIRED DRIVING ABILITY 6 0.0005
716 COUGH 148 0.0005
717 BLOOD COUNT ABNORMAL 8 0.0005
718 OCULAR HYPERAEMIA 25 0.0005
719 THERAPY CESSATION 27 0.0005
720 DERMATITIS 11 0.0005
721 INCREASED APPETITE 10 0.0005
722 MOUTH ULCERATION 11 0.0005
723 EPISTAXIS 39 0.0005
724 POST PROCEDURAL COMPLICATION 10 0.0005
725 INFLUENZA 58 0.0005
726 COVID-19 91 0.0005
727 MADAROSIS 6 0.0005
728 RASH MACULAR 18 0.0005
729 ANAEMIA 98 0.0005
730 BASAL CELL CARCINOMA 8 0.0005
731 CHILLS 60 0.0005
732 DYSGEUSIA 38 0.0005
733 PERIPHERAL COLDNESS 7 0.0005
734 HEPATOMEGALY 5 0.0005
735 DEEP VEIN THROMBOSIS 33 0.0005
736 DEVICE LEAKAGE 22 0.0005
737 SEPTIC SHOCK 22 0.0005
738 DEPRESSED LEVEL OF CONSCIOUSNESS 20 0.0005
739 PNEUMOTHORAX 8 0.0005
740 GALLBLADDER DISORDER 9 0.0005
741 EYE IRRITATION 29 0.0005
742 MACULAR DEGENERATION 6 0.0005
743 MUSCLE RIGIDITY 6 0.0005
744 HYPOTONIA 5 0.0005
745 SKIN DISCOLOURATION 23 0.0005
746 RENAL IMPAIRMENT 42 0.0005
747 BLOOD TEST ABNORMAL 7 0.0005
748 APHASIA 15 0.0005
749 EMPHYSEMA 5 0.0005
750 MENTAL IMPAIRMENT 12 0.0005
751 EYELID PTOSIS 5 0.0005
752 NIGHTMARE 17 0.0005
753 BLOOD CREATININE INCREASED 32 0.0005
754 ACUTE KIDNEY INJURY 75 0.0005
755 THERAPY INTERRUPTED 35 0.0005
756 NEOPLASM PROGRESSION 17 0.0005
757 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
758 SPINAL OPERATION 6 0.0005
759 CATARACT 29 0.0005
760 MANIA 8 0.0005
761 PHARYNGITIS 6 0.0005
762 COMA 23 0.0005
763 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
764 FLUID OVERLOAD 7 0.0005
765 CHEST DISCOMFORT 49 0.0005
766 TREMOR 79 0.0005
767 HYPOTENSION 95 0.0005
768 MUSCULOSKELETAL DISORDER 9 0.0005
769 FEELING JITTERY 9 0.0005
770 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
771 RENAL INJURY 14 0.0005
772 HAEMATOCHEZIA 26 0.0005
773 GLAUCOMA 9 0.0005
774 RESPIRATORY FAILURE 34 0.0005
775 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
776 POOR QUALITY SLEEP 10 0.0005
777 OVERDOSE 100 0.0005
778 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
779 CARDIAC FAILURE CONGESTIVE 37 0.0005
780 LEUKOPENIA 23 0.0005
781 CHOLELITHIASIS 15 0.0005
782 ALANINE AMINOTRANSFERASE INCREASED 28 0.0005
783 IMMUNE SYSTEM DISORDER 6 0.0005
784 TOOTH INFECTION 6 0.0005
785 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
786 THERAPEUTIC RESPONSE SHORTENED 15 0.0005
787 FUNGAL INFECTION 15 0.0004
788 HYPERTENSIVE CRISIS 5 0.0004
789 CYTOKINE RELEASE SYNDROME 9 0.0004
790 COLITIS 17 0.0004
791 INJECTION SITE URTICARIA 11 0.0004
792 RENAL FAILURE ACUTE 19 0.0004
793 SWELLING FACE 29 0.0004
794 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
795 HEAD INJURY 14 0.0004
796 TOOTHACHE 8 0.0004
797 DISEASE RECURRENCE 21 0.0004
798 MOOD ALTERED 12 0.0004
799 HAEMATURIA 15 0.0004
800 SENSORY DISTURBANCE 7 0.0004
801 PLASMA CELL MYELOMA 17 0.0004
802 PROSTATIC SPECIFIC ANTIGEN INCREASED 6 0.0004
803 ABDOMINAL PAIN LOWER 11 0.0004
804 SEIZURE 50 0.0004
805 PERICARDIAL EFFUSION 10 0.0004
806 MENTAL STATUS CHANGES 12 0.0004
807 EYELID OEDEMA 5 0.0004
808 APHONIA 6 0.0004
809 MASS 6 0.0004
810 DISORIENTATION 17 0.0004
811 PLEURAL EFFUSION 26 0.0004
812 HALLUCINATION, VISUAL 9 0.0004
813 MULTIPLE FRACTURES 7 0.0004
814 DIPLOPIA 11 0.0004
815 DISEASE PROGRESSION 50 0.0004
816 LOSS OF CONSCIOUSNESS 54 0.0004
817 BLOOD URINE PRESENT 8 0.0004
818 BLOOD IRON DECREASED 5 0.0004
819 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
820 THROMBOCYTOPENIA 47 0.0004
821 SKIN DISORDER 14 0.0004
822 HAEMOGLOBIN DECREASED 43 0.0004
823 PRURITUS GENERALISED 9 0.0004
824 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 75 0.0004
825 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
826 IRRITABILITY 25 0.0004
827 CRYING 15 0.0004
828 ENCEPHALOPATHY 10 0.0004
829 SKIN HAEMORRHAGE 6 0.0004
830 ABNORMAL WEIGHT GAIN 5 0.0004
831 ORAL PAIN 9 0.0004
832 SNEEZING 9 0.0004
833 INJECTION SITE BRUISING 32 0.0004
834 AMENORRHOEA 7 0.0004
835 PRODUCT DOSE OMISSION 26 0.0004
836 METASTASES TO LIVER 7 0.0004
837 THERAPEUTIC RESPONSE DECREASED 24 0.0004
838 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
839 DRUG ERUPTION 7 0.0004
840 DYSKINESIA 16 0.0004
841 THIRST 7 0.0004
842 RENAL FAILURE 52 0.0004
843 INCORRECT DRUG ADMINISTRATION DURATION 11 0.0004
844 PHARYNGEAL OEDEMA 6 0.0004
845 HAEMATOMA 10 0.0004
846 NERVOUS SYSTEM DISORDER 12 0.0004
847 ERYTHEMA 78 0.0004
848 PRODUCT PRESCRIBING ERROR 9 0.0004
849 DYSMENORRHOEA 5 0.0004
850 EYE SWELLING 14 0.0004
851 ABSCESS 6 0.0004
852 THINKING ABNORMAL 7 0.0004
853 BACTERIAL INFECTION 7 0.0004
854 CARDIAC DISORDER 35 0.0004
855 FLUSHING 38 0.0004
856 SKIN CANCER 8 0.0004
857 HYPOXIA 13 0.0004
858 INFLUENZA LIKE ILLNESS 30 0.0004
859 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20 0.0004
860 OSTEONECROSIS OF JAW 9 0.0004
861 APPLICATION SITE PAIN 8 0.0004
862 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
863 AGEUSIA 9 0.0004
864 CHOKING 7 0.0004
865 SKIN FISSURES 7 0.0004
866 HYPERGLYCAEMIA 13 0.0004
867 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
868 MULTIPLE SCLEROSIS 17 0.0004
869 FEMUR FRACTURE 11 0.0004
870 CARDIOVASCULAR DISORDER 9 0.0004
871 CHROMATURIA 8 0.0004
872 AGITATION 26 0.0004
873 SWOLLEN TONGUE 11 0.0004
874 ERECTILE DYSFUNCTION 9 0.0004
875 ANGINA PECTORIS 10 0.0003
876 UNRESPONSIVE TO STIMULI 9 0.0003
877 HYPOACUSIS 15 0.0003
878 NO ADVERSE EVENT 63 0.0003
879 EMOTIONAL DISTRESS 42 0.0003
880 ANOSMIA 5 0.0003
881 HYPERTHYROIDISM 5 0.0003
882 DRY SKIN 46 0.0003
883 PSORIASIS 45 0.0003
884 ECZEMA 18 0.0003
885 MUCOSAL INFLAMMATION 9 0.0003
886 SEDATION 9 0.0003
887 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
888 SYRINGE ISSUE 6 0.0003
889 HIP FRACTURE 11 0.0003
890 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
891 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
892 COLON CANCER 5 0.0003
893 BONE LOSS 5 0.0003
894 OSTEOMYELITIS 6 0.0003
895 LOCALISED INFECTION 8 0.0003
896 PALLOR 9 0.0003
897 INTERSTITIAL LUNG DISEASE 16 0.0003
898 LIP SWELLING 11 0.0003
899 DIABETES MELLITUS 25 0.0003
900 RESTLESSNESS 12 0.0003
901 RESPIRATORY DISTRESS 9 0.0003
902 ABNORMAL DREAMS 9 0.0003
903 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
904 ABASIA 8 0.0003
905 EJECTION FRACTION DECREASED 5 0.0003
906 CYANOSIS 5 0.0003
907 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
908 NEUTROPENIA 43 0.0003
909 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
910 HYPERKALAEMIA 11 0.0003
911 BLOOD GLUCOSE DECREASED 15 0.0003
912 RHABDOMYOLYSIS 13 0.0003
913 DRUG INTERACTION 49 0.0003
914 SPEECH DISORDER 16 0.0003
915 PSYCHOTIC DISORDER 9 0.0003
916 ABNORMAL BEHAVIOUR 12 0.0003
917 CARDIAC ARREST 25 0.0003
918 MALIGNANT NEOPLASM PROGRESSION 31 0.0003
919 DRUG LEVEL INCREASED 5 0.0003
920 BLOOD UREA INCREASED 5 0.0003
921 THROMBOSIS 24 0.0003
922 PRODUCT PHYSICAL ISSUE 6 0.0003
923 SKIN EXFOLIATION 25 0.0003
924 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 60 0.0003
925 HEMIPARESIS 5 0.0003
926 PNEUMONITIS 8 0.0003
927 INJECTION SITE RASH 9 0.0003
928 ACNE 22 0.0003
929 CARDIO-RESPIRATORY ARREST 12 0.0003
930 DEVICE MALFUNCTION 20 0.0003
931 RETCHING 6 0.0003
932 SKIN BURNING SENSATION 20 0.0003
933 PRODUCT PRESCRIBING ISSUE 6 0.0003
934 CARDIAC FAILURE 22 0.0003
935 PULMONARY EMBOLISM 26 0.0003
936 STEVENS-JOHNSON SYNDROME 6 0.0003
937 PANCREATITIS ACUTE 6 0.0003
938 APPLICATION SITE PRURITUS 6 0.0003
939 FRACTURE 5 0.0003
940 BRADYCARDIA 14 0.0003
941 PRODUCT AVAILABILITY ISSUE 6 0.0003
942 INCORRECT DOSE ADMINISTERED 60 0.0003
943 DRUG WITHDRAWAL SYNDROME 23 0.0003
944 BONE DENSITY DECREASED 8 0.0003
945 RESPIRATORY ARREST 7 0.0003
946 INJECTION SITE PRURITUS 17 0.0003
947 DEMENTIA 7 0.0003
948 INJECTION SITE ERYTHEMA 31 0.0002
949 HAEMORRHAGE 26 0.0002
950 MULTIPLE SCLEROSIS RELAPSE 17 0.0002
951 PULMONARY OEDEMA 11 0.0002
952 LIVER FUNCTION TEST ABNORMAL 7 0.0002
953 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
954 APPLICATION SITE ERYTHEMA 6 0.0002
955 GASTROINTESTINAL HAEMORRHAGE 19 0.0002
956 HYPOGLYCAEMIA 11 0.0002
957 CEREBROVASCULAR ACCIDENT 38 0.0002
958 CEREBRAL HAEMORRHAGE 8 0.0002
959 INJECTION SITE SWELLING 17 0.0002
960 LIMB INJURY 6 0.0002
961 DEATH 184 0.0002
962 INJECTION SITE HAEMORRHAGE 17 0.0002
963 DEVICE ISSUE 19 0.0002
964 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
965 NEOPLASM MALIGNANT 14 0.0002
966 ACUTE MYOCARDIAL INFARCTION 6 0.0002
967 BLOOD GLUCOSE INCREASED 38 0.0002
968 ANAPHYLACTIC REACTION 11 0.0002
969 EXTRA DOSE ADMINISTERED 8 0.0002
970 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
971 DEAFNESS 5 0.0002
972 INJECTION SITE MASS 7 0.0002
973 INJECTION SITE PAIN 57 0.0002
974 MENTAL DISORDER 8 0.0002
975 MYOCARDIAL INFARCTION 32 0.0002
976 EXPIRED PRODUCT ADMINISTERED 6 0.0002
977 SKIN IRRITATION 8 0.0002
978 DRUG DEPENDENCE 28 0.0002
979 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
980 DERMATITIS ATOPIC 9 0.0002
981 PRODUCT ADHESION ISSUE 6 0.0002
982 DEVICE DISLOCATION 7 0.0002
983 PRODUCT STORAGE ERROR 12 0.0001
984 HEPATIC FUNCTION ABNORMAL 5 0.0001
985 DRUG DOSE OMISSION 22 0.0001
986 ABORTION SPONTANEOUS 5 0.0001
987 BLINDNESS 5 0.0001
988 DRUG EFFECT DECREASED 6 0.0001
989 TOXICITY TO VARIOUS AGENTS 18 0.0001
990 SUICIDE ATTEMPT 6 0.0001
991 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
992 INTENTIONAL OVERDOSE 6 0.0001
993 BREAST CANCER 8 0.0001